SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Jul-21 11:42 AM View: | Teligent, Inc. (TLGT) | 16-Jul-21 | Payment of Exercise | 2,656 | $0.47 | $1,248.32 | (34%) 7.83K to 5.18K | 65% |
20-Jul-21 11:42 AM View: | Teligent, Inc. (TLGT) | 16-Jul-21 | Option Exercise | 7,835 | -- | -- | (261167%) (-3) to 7.83K | |
17-Oct-13 2:14 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Oct-13 | Market Sale | 213,156 | $0.10 | $20,835.20 | (70%) 303.7K to 90.55K | 41% |
06-Feb-13 10:17 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Feb-13 | Market Sale (Planned) | 30,500 | $1.01 | $30,837.00 | (9%) 334.2K to 303.7K | 45% |
16-Jan-13 4:07 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Jan-13 | Market Sale (Planned) | 1,283 | $1.14 | $1,462.62 | (< 1%) 335.48K to 334.2K | 51% |
29-Feb-12 4:01 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 27-Feb-12 | Grant | 100,000 | $2.10 | $210,000.00 | 42% 235.48K to 335.48K | (73%) |
23-Feb-12 12:22 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Feb-12 | Market Sale (Planned) | 3,540 | $2.02 | $7,150.80 | (1%) 239.02K to 235.48K | 72% |
13-Feb-12 6:34 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 01-Feb-12 | Grant | 50,000 | $2.26 | $113,000.00 | 26% 189.02K to 239.02K | (75%) |
16-Sep-11 7:04 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-11 | Market Purchase | 7,000 | $4.13 | $28,910.00 | 4% 182.02K to 189.02K | (86%) |
15-Feb-11 6:04 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Feb-11 | Market Sale (Planned) | 3,210 | $9.88 | $31,724.40 | (2%) 185.23K to 182.02K | 94% |
20-Sep-10 4:46 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-10 | Grant | 22,918 | $20.27 | $464,548.00 | 13% 170.43K to 193.35K | (97%) |
20-Sep-10 4:46 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Sep-10 | Payment of Exercise | 8,118 | $20.27 | $164,552.00 | (4%) 193.35K to 185.23K | 97% |
17-Feb-10 3:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 16-Feb-10 | Market Sale (Planned) | 5,778 | $13.79 | $79,705.50 | (3%) 172.91K to 167.13K | 96% |
10-Dec-09 4:37 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 09-Dec-09 | Market Sale (Planned) | 5,418 | $13.31 | $72,117.90 | (3%) 178.32K to 172.91K | 96% |
15-Sep-09 5:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Sep-09 | Market Sale | 3,750 | $16.25 | $60,937.50 | (2%) 182.07K to 178.32K | 96% |
15-Sep-09 5:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Sep-09 | Market Sale | 3,750 | $15.75 | $59,062.50 | (2%) 185.82K to 182.07K | 96% |
19-Feb-09 5:22 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 17-Feb-09 | Market Sale (Planned) | 5,868 | $5.73 | $33,634.80 | (3%) 191.69K to 185.82K | 90% |
19-Feb-09 5:22 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 13-Feb-09 | Grant | 25,000 | $5.94 | $148,500.00 | (12%) 216.69K to 191.69K | 90% |
10-Dec-08 3:53 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 09-Dec-08 | Market Sale (Planned) | 6,400 | $4.86 | $31,104.00 | (4%) 173.09K to 166.69K | 88% |
10-Dec-08 3:53 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 08-Dec-08 | Grant | 15,000 | $4.53 | $67,950.00 | 9% 158.09K to 173.09K | (87%) |
06-Nov-08 5:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Nov-08 | Grant | 22,500 | $5.17 | $116,325.00 | 15% 145.81K to 168.31K | (88%) |
06-Nov-08 5:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Nov-08 | Payment of Exercise | 10,220 | $5.17 | $52,837.40 | (6%) 168.31K to 158.09K | 88% |
16-Apr-08 3:43 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 14-Apr-08 | Market Sale (Planned) | 3,785 | $19.00 | $71,919.20 | (3%) 149.6K to 145.81K | 97% |
06-Mar-08 4:14 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 05-Mar-08 | Grant | 20,750 | $23.01 | $477,458.00 | 15% 138.27K to 159.02K | (97%) |
06-Mar-08 4:14 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 05-Mar-08 | Payment of Exercise | 9,425 | $23.49 | $221,406.00 | (6%) 159.02K to 149.6K | 97% |
20-Feb-08 4:59 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 20-Feb-08 | Market Sale (Planned) | 2,455 | $20.01 | $49,113.30 | (2%) 140.73K to 138.27K | 97% |
20-Feb-08 4:59 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Feb-08 | Market Sale (Planned) | 2,361 | $20.01 | $47,232.80 | (2%) 143.09K to 140.73K | 97% |
09-Jan-08 5:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 08-Jan-08 | Option Exercise | 5,000 | $2.42 | $12,100.00 | 3% 143.09K to 148.09K | |
09-Jan-08 5:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 08-Jan-08 | Market Option Sale | 5,000 | $23.15 | $115,760.00 | (3%) 148.09K to 143.09K | 97% |
09-Jan-08 5:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 07-Jan-08 | Option Exercise | 5,000 | $2.69 | $13,450.00 | 3% 143.09K to 148.09K | |
09-Jan-08 5:33 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 07-Jan-08 | Market Option Sale | 5,000 | $23.02 | $115,105.00 | (3%) 148.09K to 143.09K | 97% |
04-Jan-08 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Jan-08 | Option Exercise | 5,000 | $2.78 | $13,900.00 | 3% 143.09K to 148.09K | |
04-Jan-08 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Jan-08 | Market Option Sale | 5,000 | $23.27 | $116,331.00 | (3%) 148.09K to 143.09K | 97% |
04-Jan-08 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 03-Jan-08 | Option Exercise | 5,000 | $2.69 | $13,450.00 | 3% 143.09K to 148.09K | |
04-Jan-08 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 03-Jan-08 | Market Option Sale | 5,000 | $24.26 | $121,286.00 | (3%) 148.09K to 143.09K | 98% |
04-Jan-08 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 02-Jan-08 | Option Exercise | 5,000 | $2.42 | $12,100.00 | 3% 143.09K to 148.09K | |
04-Jan-08 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 02-Jan-08 | Market Option Sale | 5,000 | $23.47 | $117,330.00 | (3%) 148.09K to 143.09K | 97% |
12-Dec-07 4:53 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 10-Dec-07 | Market Sale (Planned) | 7,774 | $15.22 | $118,344.00 | (5%) 150.86K to 143.09K | 96% |
16-Apr-07 3:23 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 12-Apr-07 | Market Sale (Planned) | 3,805 | $12.06 | $45,903.50 | (2%) 154.67K to 150.86K | 95% |
07-Mar-07 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 05-Mar-07 | Grant | 45,750 | $12.51 | $572,332.00 | 35% 129.8K to 175.55K | (95%) |
07-Mar-07 4:49 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 05-Mar-07 | Market Sale (Planned) | 20,881 | $12.53 | $261,639.00 | (12%) 175.55K to 154.67K | 95% |
20-Feb-07 5:13 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Feb-07 | Grant | 20,790 | -- | -- | 19% 112.06K to 132.85K | |
20-Feb-07 5:13 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Feb-07 | Market Sale (Planned) | 3,051 | $14.44 | $44,045.50 | (2%) 132.85K to 129.8K | 96% |
12-Dec-06 7:05 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 08-Dec-06 | Grant | 45,000 | -- | -- | 67% 67.06K to 112.06K | |
13-Apr-06 1:38 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 12-Apr-06 | Market Sale (Planned) | 4,992 | $5.87 | $29,297.10 | (7%) 72.05K to 67.06K | 90% |
22-Feb-06 5:10 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 15-Feb-06 | Grant | 20,000 | -- | -- | 38% 52.05K to 72.05K | |
19-May-05 9:14 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 18-May-05 | Market Purchase | 10,000 | $3.18 | $31,840.00 | 24% 42.05K to 52.05K | (81%) |
15-Apr-05 12:36 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 13-Apr-05 | Grant | 32,050 | -- | -- | 320% 10.0K to 42.05K | |
07-Jun-04 2:42 PM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 04-Jun-04 | Grant | 10,000 | $2.95 | $29,525.00 | 100% 0 to 10.0K | (80%) |
05-May-04 10:00 PM View: | Progenics Pharmaceuticals I... (PGNX) | 03-May-04 | Option Exercise | 2,000 | $12.29 | $24,580.00 | 25% 7.9K to 9.9K |